Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer

By Stadler W.M.   Hayden A.   von der Maase H.   Roychowdhury D.   Dogliotti L.   Seymour L.   Kaufmann D.   Moore M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 4, 2002-07 ,pp. : 153-157

Elsevier

Access to resources Recommend Favorite

Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine

By        

Experimental and Therapeutic Medicine, Vol. 4, Iss. 6, 2012-01 ,pp. : 1035-1038

Spandidos Publications

Access to resources Recommend Favorite

Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer

By Xu N.   Shen P.   Zhang X.   Yu L.   Bao H.   Shi G.   Huang S.   Chen J.   Mou H.   Fang W.  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 1-7

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer - a phase II trial

By Laack E.   Mende T.   Durk H.   Kneba M.   Dickgreber N.   Welte T.   Muller T.   Scholtze J.   Graeven U.   Jasiewicz Y.   Edler L.   Hossfeld D.K.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 654-660

Elsevier

Access to resources Recommend Favorite

The regimen of gemcitabine and cisplatin combined with radio frequency hyperthermia for advanced non-small cell lung cancer: A phase II study

By Shen Hua   Li Xiao-Dong   Wu Chang-Ping   Yin Yong-Mei   Wang Rong-sheng   Shu Yong-Qian  

International Journal of Hyperthermia, Vol. 27, Iss. 1, 2011-02 ,pp. : 27-32

Informa Healthcare

Access to resources Recommend Favorite